Tirofiban (Aggrastat®)
Open Access
- 1 September 1999
- journal article
- Published by Wiley in Cardiovascular Drug Reviews
- Vol. 17 (3) , 199-224
- https://doi.org/10.1111/j.1527-3466.1999.tb00015.x
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Low-Molecular-Weight HeparinsNew England Journal of Medicine, 1997
- Tirofiban provides “platelet anesthesia” during cardiopulmonary bypass in baboonsThe Journal of Thoracic and Cardiovascular Surgery, 1997
- Inhibition of platelet-mediated, tissue factor-induced thrombin generation by the mouse/human chimeric 7E3 antibody. Potential implications for the effect of c7E3 Fab treatment on acute thrombosis and "clinical restenosis".Journal of Clinical Investigation, 1996
- Randomized, double-blind, placebo-controlled dose-ranging study of tirofiban (MK-383) platelet IIb/IIIa blockade in high risk patients undergoing coronary angioplastyJournal of the American College of Cardiology, 1996
- Antiplatelet, antithrombotic, and lytic therapy for unstable angina, and the appropriate role of revascularizationCurrent Opinion in Cardiology, 1995
- EnoxaparinDrugs, 1995
- Novel antithrombotic approaches to coronary artery diseaseThe American Journal of Cardiology, 1995
- The pathogenesis of atherosclerosis: a perspective for the 1990sNature, 1993
- The Pathogenesis of Coronary Artery Disease and the Acute Coronary SyndromesNew England Journal of Medicine, 1992
- The Pathogenesis of Coronary Artery Disease and the Acute Coronary SyndromesNew England Journal of Medicine, 1992